Mehraj U - Search Results

1

Expression Pattern and Prognostic Significance of Chemokines in Breast cancer: An Integrated Bioinformatics Analysis.

Mehraj U, Alshehri B, Khan AA, Bhat AA, Bagga P, Wani NA, Mir MA. Mehraj U, et al. Clin Breast Cancer. 2022 Aug;22(6):567-578. doi: 10.1016/j.clbc.2022.04.008. Epub 2022 Apr 25. Clin Breast Cancer. 2022. PMID: 35585016

2

Tumor microenvironment promotes breast cancer chemoresistance.

Mehraj U, Dar AH, Wani NA, Mir MA. Mehraj U, et al. Cancer Chemother Pharmacol. 2021 Feb;87(2):147-158. doi: 10.1007/s00280-020-04222-w. Epub 2021 Jan 9. Cancer Chemother Pharmacol. 2021. PMID: 33420940 Review.

3

Prognostic significance and targeting tumor-associated macrophages in cancer: new insights and future perspectives.

Mehraj U, Qayoom H, Mir MA. Mehraj U, et al. Breast Cancer. 2021 May;28(3):539-555. doi: 10.1007/s12282-021-01231-2. Epub 2021 Mar 4. Breast Cancer. 2021. PMID: 33661479 Review.

4

The tumor microenvironment as driver of stemness and therapeutic resistance in breast cancer: New challenges and therapeutic opportunities.

Mehraj U, Ganai RA, Macha MA, Hamid A, Zargar MA, Bhat AA, Nasser MW, Haris M, Batra SK, Alshehri B, Al-Baradie RS, Mir MA, Wani NA. Mehraj U, et al. Cell Oncol (Dordr). 2021 Dec;44(6):1209-1229. doi: 10.1007/s13402-021-00634-9. Epub 2021 Sep 16. Cell Oncol (Dordr). 2021. PMID: 34528143 Review.

5

Expression pattern and prognostic significance of CDKs in breast cancer: An integrated bioinformatic study.

Mehraj U, Sofi S, Alshehri B, Mir MA. Mehraj U, et al. Cancer Biomark. 2022;34(3):505-519. doi: 10.3233/CBM-210186. Cancer Biomark. 2022. PMID: 35491766

6

Chemokines in triple-negative breast cancer heterogeneity: New challenges for clinical implications.

Mehraj U, Mushtaq U, Mir MA, Saleem A, Macha MA, Lone MN, Hamid A, Zargar MA, Ahmad SM, Wani NA. Mehraj U, et al. Semin Cancer Biol. 2022 Nov;86(Pt 2):769-783. doi: 10.1016/j.semcancer.2022.03.008. Epub 2022 Mar 9. Semin Cancer Biol. 2022. PMID: 35278636 Review.

7

Cryptolepine Targets TOP2A and Inhibits Tumor Cell Proliferation in Breast Cancer Cells - An In vitro and In silico Study.

Mehraj U, Qayoom H, Shafi S, Farhana P, Asdaq SMB, Mir MA. Mehraj U, et al. Anticancer Agents Med Chem. 2022;22(17):3025-3037. doi: 10.2174/1871520622666220419135547. Anticancer Agents Med Chem. 2022. PMID: 35440335

8

Cyclin-dependent kinases in breast cancer: expression pattern and therapeutic implications.

Sofi S, Mehraj U, Qayoom H, Aisha S, Asdaq SMB, Almilaibary A, Mir MA. Sofi S, et al. Among authors: mehraj u. Med Oncol. 2022 Apr 29;39(6):106. doi: 10.1007/s12032-022-01731-x. Med Oncol. 2022. PMID: 35486263 Review.

9

Adapalene inhibits the growth of triple-negative breast cancer cells by S-phase arrest and potentiates the antitumor efficacy of GDC-0941.

Mehraj U, Wani NA, Hamid A, Alkhanani M, Almilaibary A, Mir MA. Mehraj U, et al. Front Pharmacol. 2022 Aug 8;13:958443. doi: 10.3389/fphar.2022.958443. eCollection 2022. Front Pharmacol. 2022. PMID: 36003501 Free PMC article.

10

Targeting Different Pathways Using Novel Combination Therapy in Triple Negative Breast Cancer.

Mir MA, Qayoom H, Mehraj U, Nisar S, Bhat B, Wani NA. Mir MA, et al. Among authors: mehraj u. Curr Cancer Drug Targets. 2020;20(8):586-602. doi: 10.2174/1570163817666200518081955. Curr Cancer Drug Targets. 2020. PMID: 32418525 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Search Page

Filters